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Abstract
Background:  Human infections with Sin Nombre virus (SNV) and related New World
hantaviruses often lead to hantavirus cardiopulmonary syndrome (HCPS), a sometimes fatal illness.
Lungs of patients who die from HCPS exhibit cytokine-producing mononuclear infiltrates and
pronounced pulmonary inflammation. Deer mice (Peromyscus maniculatus) are the principal natural
hosts of SNV, in which the virus establishes life-long persistence without conspicuous pathology.
Little is known about the mechanisms SNV employs to evade the immune response of deer mice,
and experimental examination of this question has been difficult because of a lack of methodologies
for examining such responses during infection. One such deficiency is our inability to characterize
T cell responses because susceptible syngeneic deer mice are not available.
Results: To solve this problem, we have developed an in vitro method of expanding and generating
competent antigen presenting cells (APC) from deer mouse bone marrow using commercially-
available house mouse (Mus musculus) granulocyte-macrophage colony stimulating factor. These
cells are capable of processing and presenting soluble protein to antigen-specific autologous helper
T cells in vitro. Inclusion of antigen-specific deer mouse antibody augments T cell stimulation,
presumably through Fc receptor-mediated endocytosis.
Conclusions: The use of these APC has allowed us to dramatically expand deer mouse helper T
cells in culture and should permit extensive characterization of T cell epitopes. Considering the
evolutionary divergence between deer mice and house mice, it is probable that this method will be
useful to other investigators using unconventional models of rodent-borne diseases.
Background
Hantaviruses (family Bunyaviridae) are rodent-borne and
can cause hemorrhagic fever with renal syndrome
(HFRS4) or hantavirus cardiopulmonary syndrome
(HCPS) [1]. While HFRS is usually associated with Eura-
sian hantaviruses, HCPS is caused by any of several
recently described New World hantaviruses [2-4]. In
North America, the great majority of HCPS cases have
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occurred in the western United States and Canada and
were caused by Sin Nombre virus (SNV).
Patients afflicted with HCPS exhibit pronounced pulmo-
nary inflammation due to capillary leak syndrome, with
the consequent hypotension often leading to rapid
decline and death [5]. Virus is found in the lungs of
infected humans, but without discernible cytopathology,
and mononuclear infiltrates are observed that produce
proinflammatory cytokines, including IL-2, IL-4, IFN-γ,
TNF and lymphotoxin (LT) [6], suggesting that HCPS is an
immunopathologic response to the virus. To date, more
than 370 infections with hantavirus have been docu-
mented in the United States, with a 36% fatality rate.
Deer mice (Peromyscus maniculatus) are the principal reser-
voir host of SNV [4,7]. As is usual with some natural hosts,
SNV infection of deer mice does not result in discernible
pathology [8]. Infection parallels that of humans, with
virus infecting capillary endothelial cells in many tissues,
including the lungs, but without conspicuous cytopathol-
ogy. However, in contrast to human HCPS, no pulmonary
inflammation, capillary leakage, or mononuclear infil-
trates are observed, and most, if not all, deer mice remain
persistently infected for the remainder of their lives [9].
Deer mice are among the most common mammals in
North America, found from the subarctic to central Mex-
ico, except for the Atlantic seaboard and the southeast
United States where other peromyscine species predomi-
nate [10,11]. Serosurveys of natural rodent populations
suggest that hantavirus infections occur throughout the
range of deer mice [7,12-15], which thus poses a potential
threat to individuals who are in contact with these
rodents. In addition, deer mice and other peromyscine
rodents have been shown to harbor other human patho-
gens [16-28].
Very little is known about the mechanism by which the
deer mouse immune system engages SNV because few rea-
gents and methodologies have been developed and no
susceptible inbred deer mice are available. The only useful
immunological data that can be acquired is by use of
serology; infected deer mice produce a neutralizing IgG
response that is inadequate to clear the virus [8,9,29]. We
previously cloned several deer mouse cytokine genes [30-
32], but quantitative assays for the detection of the expres-
sion of these genes have not been developed. These limi-
tations have made it difficult to determine what
immunological events occur that impair an effective
immune response without pathology. In some viral infec-
tions, persistence has been shown to occur because of
impairment of helper and cytotoxic T cell responses, anti-
gen presenting cell (APC) function, and development of
APC from bone marrow progenitors [33-37]. Currently,
none of these functions can be evaluated in deer mice.
Recent advances in hematopoietic stem cell research have
identified an important role for granulocyte-macrophage
colony stimulating factor (GM-CSF) in the expansion and
maturation of bone marrow cells into competent APC
[38-40]. We previously cloned a partial cDNA represent-
ing deer mouse GM-CSF and found that one of its recep-
tor-binding domains is nearly identical to that of the
common laboratory house mouse (Mus musculus) [30].
This led us to hypothesize that house mouse GM-CSF,
which is commercially-available, might be useful in
expanding and differentiating deer mouse bone marrow
cells into competent APC. If so, then it should be possible
to generate large pools of APC from individual deer mice
that could be aliquotted and frozen for use in long-term T
cell cultures, which would preclude the necessity for
inbred deer mice. We present evidence that such cells can
be propagated in vitro and that they are capable of
processing antigen and stimulating antigen-sensitized
autologous T cells. This technique could provide sufficient
APC, such that conventional T cell cloning and peptide-
mapping experiments could be performed. In addition,
because deer mice (New World rodents) and house mice
(Old World rodents) are divergent by 25 to 50 million
years [41], it is possible that this approach may be useful
to investigators using other unconventional rodent mod-
els of infectious diseases.
Results
Cloning of the 5' end of deer mouse GM-CSF
We used RACE to obtain the complete 5' end of GM-CSF.
This sequence was translated using the default translation
table within MacVector. The polypeptide is predicted to
have a 25 residue signal peptide based upon orthologous
sequences from other species [42-45] (Figure 1). The
receptor-binding domains of deer mouse and house
mouse GM-CSF share 13/15 identical residues. This
region forms the α-helix (helix A) that binds with high
affinity to β chain subunit of the GM-CSF receptor com-
plex that is shared with the IL-3 and IL-5 receptors [46-
49].
Morphologic characteristics of bone marrow-derived APC
Deer mouse bone marrow cultures contained mostly cells
that appeared dead or dying after 24 hours in culture with
GM-CSF. However, at 48 hours clusters of cells were
apparent, while control wells without GM-CSF had fewer
live cells than at 24 hours. By day 3, adherent stromal cell
foci were conspicuous, while semiadherent and nonad-
herent cells were more evident and these became the
prominent cells for the duration of culture. Day 12 bone
marrow cells incubated for an additional 48 hours were
large, ranging from 12 to 18 µm in diameter, andBMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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possessed macropinocytic vesicles and processes (Figure
2A). Although the method that was employed selects for
DC in the house mouse [39], the deer mouse cells
appeared to resemble macrophages, with abundant cyto-
plasmic vesicles, rather than dendritic cells, with lamel-
lipodia or characteristic long processes extending from the
cell. (S. K. Chapes, pers. comm.). However, the cells' exact
definition will not be complete until better phenotypic
characterization is possible. Treatment of the cells with
recombinant TNF diminished the macropinocytic vesicles
(Figure 2B).
Proliferation of deer mouse cells to house mouse GM-CSF 
and human IL-2
Day 8 deer mouse bone marrow cells were cultured with
various concentrations of house mouse GM-CSF. Two
days later, proliferation was assessed (Figure 3A) and max-
imal proliferation was observed at about 0.5 ng/ml of
Amino acid alignment of deer mouse (DM), cotton rat (CR), house mouse (HM) and human (HU) GM-CSF Figure 1
Amino acid alignment of deer mouse (DM), cotton rat (CR), house mouse (HM) and human (HU) GM-CSF. Polypeptides were 
aligned with the clustal algorithm in Macvector. Conserved (light shading) and identical (dark shading) amino acids are enclosed 
in boxes. The 25-residue signal peptide is enclosed in box A. Helix A, which binds to the β chain subunit of the GM-CSF recep-
tor, is enclosed in box B. Deer mouse and house mouse GM-CSF share 13 of 15 identical residues in this domain.BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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GM-CSF. Deer mouse splenocytes proliferated in response
to human IL-2 (Figure 3B). In this experiment, deer
mouse splenocytes were cultured with a suboptimal con-
centration of PHA and various concentrations of recom-
binant human IL-2. Maximal proliferation occurred at 20
U/ml of IL-2. In another proliferation assay, in vitro deer
mouse T cells that were collected 8 days after stimulation
with APC and antigen exhibited slightly greater prolifera-
tion to IL-2 (data not shown).
Expression of MHC class II I-Eβ and TCRβC by deer mouse 
cells propagated in vitro
BM-APC and T cells were examined for the expression of
orthologous I-Eβ and TCRβC, respectively, by RT-PCR
(Figure 4). For I-Eβ, primers were designed from previ-
ously published deer mouse sequences [50], while prim-
ers for TCRβC were those that are described in this work.
In each instance, products of the expected sizes were
amplified. The amplified BM-APC product was cloned,
sequenced, and verified to be I-Eβ.
BM-APC induce antigen-specific proliferation of 
autologous T cells
Deer mice were immunized with keyhole limpet hemacy-
anin (KLH), and 10 days later the lymph nodes, spleens
and bone marrow were processed for in vitro expansion of
polyclonal T cells (lymph node cells), while the bone mar-
row cells and splenocytes were frozen. Sera were tested for
antibodies to KLH by ELISA and in each deer mouse tested
the titer was greater than or equal to 8,000 (data not
shown). For recall proliferation, KLH, in vitro-propagated
T cells (14 days with IL-2) and BM-APC (14 days with GM-
CSF) or freshly thawed splenocytes were cultured together
for 72 hours, and proliferation was assessed by MTS assay
(Figure 5). For each deer mouse, the BM-APC were
between 10× to 20× more efficient at stimulating antigen-
specific helper T cell proliferative responses. While each T
cell line exhibited a 50% maximal stimulation in the pres-
ence of about 10 to 20 µg/ml antigen with splenocytes,
50% maximal stimulation was usually near 1 to 2 µg/ml
antigen with BM-APC. In parallel experiments, cultures
incubated with 20 ng/ml house mouse TNF did not
exhibit noticeably different proliferative responses com-
pared to control cultures (data not shown), despite mor-
phological evidence suggesting an effect on
macropinocytosis (Figure 2).
Antibody augments BM-APC stimulation of T cells
Deer mouse antiserum raised against KLH and incubated
with antigen for one hour prior to addition of cells
increased the sensitivity of T cell proliferation (Figure 6),
suggesting that Fc receptors are present on the surface of
the BM-APC. The presence of antibody increased the 50%
maximal T cell proliferation from one deer mouse
(DM223) about 10-fold, from about 500 ng/ml without
antibody to 50 ng/ml with antibody. Similarly, for
another deer mouse (DM224) the presence of antibody
was substantially more effective at inducing T cell
Morphologic characteristics of deer mouse bone marrow-derived APC Figure 2
Morphologic characteristics of deer mouse bone marrow-derived APC. Day 14 bone marrow cells cultured in GM-CSF were 
processed by cytospin and stained with Wright's stain. The cells exhibited conspicuous cytoplasmic vesicles and small proc-
esses (A). Cells collected on day 12 and incubated for 48 hours with 20 ng/ml of hmTNF displayed less conspicuous cytoplas-
mic vesicles (B).BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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proliferation, increasing 50% max 50-fold (from 50 ng/
ml to about 1 ng/ml). Notably, the T cell response in
DM223 was also less vigorous (50% max 500 ng/ml)
without antibody compared to DM224 (50% max 50 ng/
ml). The proliferative responses of six other deer mouse T
cell lines were similar to those of these deer mice (data not
shown).
Discussion
To our knowledge, no previous efforts have been made to
develop long-term cultures of T cells from unconventional
laboratory rodents. The principal reason for this is that
highly inbred strains, required for conventional long-term
T cell work, are not available from rodents not routinely
used in laboratory work. At least for deer mice, we have
developed a method of fulfilling this need by using com-
mercially-available house mouse GM-CSF. This cytokine
apparently binds to the GM-CSF receptor on deer mouse
cells such that it generates competent APC from the bone
marrow. These cells are capable of processing and present-
ing soluble antigen to autologous antigen-specific helper
T cells.
Our initial suspicions that house mouse GM-CSF might
bind to deer mouse GM-CSF receptor was the result of pre-
vious work [30] in which we cloned a partial cDNA of deer
mouse GM-CSF, including most of its A helix that is
involved in binding to the β chain subunit of the receptor.
We used 5' RACE to obtain the complete N-terminus and
found that all but two of the residues from helix A are
identical between the two species. Subsequent experi-
ments demonstrated that GM-CSF induces proliferation
of deer mouse bone marrow cells, and since GM-CSF is
routinely used to generate APC from the bone marrow we
hypothesized that it would do so with deer mouse bone
marrow.
We used a method that has been shown to generate den-
dritic cells in house mice; however, the cells obtained
from deer mouse bone marrow more closely resembled
macrophages rather than DC. These cells contained many
large macropinocytic vesicles, but conspicuous dendrites
typical of DC were not observed. Microscopically, these
cells also appeared sensitive to TNF, which decreased mac-
ropinocytosis, but it had no effect on the capacity of these
cells to present antigen to T cells as has been reported for
human DC derived from blood mononuclear cells [51].
TNF can induce a physiologic change in the APC from an
active pinocytotic cell into one that becomes highly effi-
cient at MHC class II antigen presentation, thus facilitat-
ing transition from the innate phase to the adaptive phase
of the immune response. It is unclear why TNF treatment
does not augment T cell proliferative responses with deer
mouse APC, but it may be that species-specific differences
in GM-CSF and TNF signaling occur that account for these
disparities in APC development and behavior. It is also
possible that TNF does not induce complete maturation
of the cells into highly efficient APC, as has been reported
for some DC [52]. It is currently impossible to phenotype
these cells because no antibodies specific to deer mouse
Proliferation of deer mouse cells to recombinant cytokines Figure 3
Proliferation of deer mouse cells to recombinant cytokines. 
(A) After 8 days of incubation with GM-CSF, deer mouse 
bone marrow cells were washed and then cultured with dilu-
tions of GM-CSF in duplicate for 48 hours, then proliferation 
assessed by MTS assay. The data are representative of four 
deer mice. (B) To assess proliferative capacity of deer mouse 
T cells to human IL-2, splenocytes were cultured with a sub-
optimal dose of PHA (2 µg/ml) and dilutions of recombinant 
human IL-2 in duplicate for 48 hours, and proliferation 
assessed by MTS assay. The data are representative of two 
deer mice.BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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APC subpopulations, such as CD markers, are available,
nor have genes for these markers been cloned, despite
many attempts (unpublished observations), that might
facilitate identification of these cells. Regardless, the cells
are highly efficient at processing and presenting antigen,
and inclusion of antigen-specific antibodies augments
these functions.
Since the deer mice are outbred, this method requires the
immunization and collection of cells from individual ani-
mals (Figure 7). These cells are derived from lymph nodes
(T cell source), splenocytes (APC source) and bone mar-
row (APC source). Most of the recovered cells can be prop-
agated in vitro and/or aliquotted and stored frozen so that
viable cells can be used as necessary to propagate and
characterize helper T cell lines. We routinely recover 107
bone marrow cells from a deer mouse, which is sufficient
for freezing 5 vials at 2 × 106 cells each. Each vial is used
to seed a 100 mm bacterial Petri dish, which produces
about 107 BM-APC at 14 days of culture. For deer mice, the
most significant limitation for cells is from the spleen.
Although deer mice are slightly smaller than BALB/c mice,
their spleens are disproportionately small (unpublished
observations). We routinely recover 7 × 106 splenocytes
from a deer mouse, while BALB/c house mice usually pro-
vide 10-fold more. Because of this limitation, we have
begun to use BM-APC to propagate T cells. This method
involves culturing of bone marrow cells with GM-CSF for
10 days, then freezing aliquots of 106 cells. Three days
before T cell restimulation, the 10-day BM-APC are
thawed and cultured with GM-CSF, then used for restim-
ulation with fresh antigen in one well of a 24-well plate.
The T cells are fed fresh IL-2 DMM-5 at two-day intervals
for expansion.
We have used this method to establish nine T cell lines, six
specific for KLH and three specific for SNV nucleocapsid
antigen (data not shown). Based upon typical cell yields,
it should be possible to assay several thousand wells on
96-well plates, which we estimate to be sufficient for
many T cell activities, including cloning, peptide epitope
mapping, TCR variable gene segment usage, and cytokine
profiling.
We believe the methods described in this work will allow
the characterization of antigen presentation and T cell
responses in infected deer mice. Many viruses impair
pathways involved in APC and T cell functions so that
they can evade a sterilizing immune response. With
hantaviruses and their rodent hosts, millions of years of
evolution have presumably allowed a coadaptation of the
viruses and host immune responses such that pathology
does not occur and the virus is not eliminated. It is possi-
ble that hantaviruses possess some as yet unidentified
mechanism for suppressing an aggressive inflammatory
immune response in rodent hosts, which is ineffective in
human infections and often leads to inflammatory
immunopathology.
Because of the substantial evolutionary divergence of deer
mice and house mice (about 25–50 million years) [41], it
is likely that this method could be used with many
RT-PCR of TCRβX and MHC class II I-Eβ in deer mouse cells Figure 4
RT-PCR of TCRβC and MHC class II I-Eβ in deer mouse cells. Total RNA was extracted from T cells and bone marrow-
derived APC. Expression of the constant β chain of the TCR by the T cells and class II I-Eβ chain by the APC were detected by 
RT-PCR. β-Actin primers were used as controls for each sample.BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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divergent rodent species, and thus useful for examining
APC and T cell responses in a variety of rodent systems,
including natural hosts and animal models of disease.
A limitation of this approach is that BM-APC lose their
ability to proliferate in the presence of GM-CSF after four
to six weeks, similar to what has been observed with
house mouse bone marrow-derived cells [53,54]. Since a
finite number of bone marrow cells can be harvested, this
limitation prevents indefinite propagation of deer mouse
T cells. It is possible that competent BM-APC might be
propagated indefinitely by the introduction of oncogenes,
such as transforming retroviruses [55]. Alternatively, other
house mouse or human hematopoietic cytokines that are
commonly used to propagate bone marrow progenitor
cells may bind to deer mouse receptors. For example,
human or house mouse Flt3 ligand is active on both
human and house mouse cells, suggesting that one or
both would have an effect on deer mouse cells as well. In
BM-APC stimulate helper T cell proliferation Figure 5
BM-APC stimulate helper T cell proliferation. Deer mice 
were immunized with 20 µg of KLH subcutaneously and 10 
days later the lymph nodes, bone marrow and splenocytes 
were retrieved for expansion of helper T cells and BM-APC. 
After expansion of these cells in culture, proliferation assays 
were performed comparing mitomycin-C-treated autologous 
splenocytes (SC) and BM-APC (BMC) for their capacity to 
stimulate T cells. In each instance, the BM-APC were more 
effective at stimulating T cell responses. The data are of two 
deer mice (DM212 and DM213).
Antigen-specific antibody augments BM-APC-induced T cell  proliferation Figure 6
Antigen-specific antibody augments BM-APC-induced T cell 
proliferation. T cell proliferation responses from deer mice 
223 and 224 were assessed as described in Figure 5 using 
BM-APC. KLH-specific antiserum or normal deer mouse 
serum were diluted 1:2,000 in DMM-5 and incubated with 
dilutions of KLH for 1 hour in 96-well plates at room tem-
perature. BM-APC and T cells were added to the wells and 
incubated 72 hours, and proliferation was assessed by MTS 
assay.BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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this manner, large numbers of progenitor cells might be
produced in vitro for storage and then thawed, as needed,
for culturing in GM-CSF to produce functional APC.
Conclusions
We have developed a method for generating large num-
bers of competent antigen presenting cells from deer
mouse bone marrow using house mouse GM-CSF. This
method resulted in the production of antigen-specific T
cell lines from outbred deer mice. Inclusion of antigen-
specific antibody in cultures augments T cell proliferation,
suggesting the APC express Fc receptors. This method will
allow characterization of APC and T cells in deer mice and
may be extended to other rodent species that are impor-
tant in infectious disease research.
Methods
Deer mice
The deer mice used in these experiments were from a col-
ony of animals established with deer mice trapped in
western Colorado [30]. All procedures were approved by
the Mesa State College Institutional Animal Care and Use
Committee and in accordance with the Animal Welfare
Act.
Cloning of the deer mouse GM-CSF 5' cDNA
The 5' end of the deer mouse GM-CSF cDNA was obtained
by using RACE. Briefly, a primer (Table 1) was designed
from a partial cDNA of deer mouse GM-CSF [30] and used
to amplify the 5' end according to manufacturer's direc-
tions (SMART RACE, BD CLONTech, Palo Alto, CA) using
con A-activated spleen cell culture cDNA. The fragment
was cloned into pGEM-T Easy (Promega, Madison, WI)
and sequenced using the Big Dye Terminator sequencing
kit (Applied Biosystems, Foster City, CA) and an ABI 310
DNA Analyzer, and the sequence was deposited into Gen-
bank (AY247762). The signal peptide and receptor-bind-
ing domain was identified by comparison to house mouse
GM-CSF [49]. GM-CSF polypeptides from the house
mouse (X02333), cotton rat (Sigmodon hispidus,
AAL55394) and human (NP_000749) were aligned using
MacVector's (Accelrys, San Diego, CA) clustal algorithm.
Cloning of the deer mouse T cell receptor β constant 
domain cDNA
Total RNA from activated splenocytes was reverse-tran-
scribed using an oligo-dT primer and Superscript II (Invit-
rogen, Carlsbad, CA). TCRβC cDNA sequences from
house mouse, rat and human were aligned with MacVec-
tor. PCR primers (Table 1) were designed from highly
conserved regions within the alignment. PCR was per-
formed on activated splenocytes with 95°C for 30 sec,
58°C for 30 sec, and 72°C for 1 min for 35 cycles. The
amplified fragment was cloned and sequenced as
described above, and deposited into Genbank
(AY307417).
Immunization of deer mice
Deer mice were bilaterally immunized subcutaneously at
the base of the tail with 20 µg of KLH (Sigma Chemical
Co, St. Louis, MO) emulsified in CFA (Sigma). Ten days
later, draining lymph nodes, spleens and bone marrow
were recovered for in vitro experiments. For production of
high-titer KLH antiserum, deer mice were immunized i.p.
with 20 µg of KLH emulsified in CFA and boosted with 20
µg in IFA one month later. Sera were collected 7 days after
boosting.
Processing of tissues from immunized deer mice
Immunized deer mice were euthanized by cervical dislo-
cation and the draining lymph nodes, spleens and bone
marrow from individual animals were separately collected
in Hank's balanced salt solution for processing. The
lymph nodes served as a source of antigen-specific T cells,
while the splenocytes were treated with ammonium chlo-
ride (Cambrex Bioproducts, Walkersville, MD) to lyse
RBCs, then frozen in 10% DMSO/5% FBS deer mouse
medium (DMM-5: 5% FBS, RPMI-1640 supplemented to
315 mOsm [with 2.5 ml of 5 M NaCl/L], 2.5 µg/ml Fung-
izone, 100 U/ml penicillin, 100 µg/ml streptomycin, 50
µg/ml gentamicin, 50 µM β-ME, 10 mM HEPES, 2 mM L-
glutamine) in aliquots for use as autologous APC for addi-
tional rounds of in vitro T cell stimulation. The bone mar-
row cells were collected from tibiae and femurs, washed
Schematic overview of the process for culturing autologous  deer mouse BM-APC and T cells Figure 7
Schematic overview of the process for culturing autologous 
deer mouse BM-APC and T cells. Ten days post immuniza-
tion, lymph nodes, spleens and bone marrow are harvested 
from euthanized deer mice. The lymph node cells are cul-
tured with antigen for four days, while the splenocytes and 
bone marrow cells are frozen at -70°C. On day 4, the blast-
ing lymph node T cells are recovered and cultured with fresh 
antigen and thawed splenocytes (without mitomycin-C treat-
ment). Simultaneously, bone marrow cells are thawed and 
cultured with GM-CSF. Expansion of the T cells is performed 
with huIL-2 and the BM-APC with GM-CSF for 14 days. 
These cells are then used for proliferation experiments.BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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twice in DMM-5, and aliquotted at 2 × 106 cells per vial in
1 ml of 10% DMSO/DMM-5 and stored at -70°C.
Bone marrow culture
Bone marrow-derived APC (BM-APC) were generated
with modification of a previously described method for
dendritic cells (DC) [39]. One vial of bone marrow cells
(2 × 106) was quick-thawed in a 37°C water bath and cul-
tured without washing in 100 mm bacterial Petri dishes in
DMM-10 containing 20 ng/ml recombinant house mouse
GM-CSF (R&D Systems, Minneapolis, MN) at 37°C under
7% CO2. Fresh GM-CSF/DMM-10 was provided on days
3, 6, 8, 10, and 12 for the generation of APC. Cells were
collected with a scraper for use in experiments. Cells were
processed by cytospin and stained with Wright's stain for
morphological examination.
Assessment of T cell sensitivity to human IL-2
Deer mouse splenocytes depleted of RBC by ammonium
chloride treatment were incubated with a suboptimal
dose of PHA (2 µg/ml) (Sigma) in DMM-5 and recom-
binant human IL-2 (R&D Systems) for 48 hours. Prolifer-
ation was determined by MTS assay (Cell Titer-96 AQ,
Promega). The means and standard deviations of dupli-
cate samples were calculated, with the mean of cells with-
out IL-2 subtracted from sample means.
Assessment of T cell receptor and MHC class II expression
Total RNA was extracted from 14 day T cell and BM-APC
cultures (Versagene RNA, Gentra Systems, Minneapolis,
MN) and converted into cDNA. Class II expression of the
bone marrow cells was assessed by PCR using a forward
primer from exon 2 and a reverse primer that overlaps the
boundaries of exons 2 and 3 of deer mouse I-Eβ (Table
1[50]). The amplified fragment was cloned and
sequenced as described above. T cells were defined by PCR
amplification of the TCRβC chain using the primers listed
above (forward, exon 1; reverse, exon 2). β-Actin expres-
sion was assessed for each population.
ELISA serology
Sera were collected at euthanasia by cardiac puncture.
Plates were coated with 5 µg/ml KLH in PBS overnight and
washed 5× with wash buffer (PBS-0.1% TWEEN-20).
Plates were then blocked with blocking buffer (5% nonfat
powdered milk in wash buffer) for 1 hour at room tem-
perature. The sera and remaining reagents were diluted in
blocking buffer. Sera were incubated in duplicate for 2
hours at room temperature, followed by goat anti-P. leuco-
pus IgG (H&L) (KPL, Gaithersburg, MD) for 1 hour, then
horse anti-goat IgG-HRP conjugate for 1 hour (Vector,
Burlingame, CA). ABTS substrate (Sigma) was incubated
for 15 min, and plates were read at 414 nm. Means were
calculated with the background (1:100 normal deer
mouse serum) subtracted.
In vitro helper T cell expansion
In vitro stimulation of helper T cells was performed essen-
tially as described elsewhere [56,57]. Lymph nodes from
immunized deer mice were made into single-cell suspen-
sions by gently disrupting the capsule between the ends of
sterile frosted microscope slides. The cells were washed
twice in HBSS and plated at 5 × 106 cells per well (24 well
plate) with 20 µg/ml KLH in DMM-5. After a 4 day
incubation, the lymph node cells were collected and
washed twice in DMM-5. The number of recovered lymph
node cells varied between animals, but between 2 × 105
and 5 × 105 cells were recovered and plated with fresh
antigen and 3 × 106 thawed autologous splenocytes in
DMM-5 in 24 well plates in 1 ml of DMM-5. At 2 day
intervals, cultures were fed by removing 750 µl of media
and replacing it with DMM-5 containing 20 U/ml of
recombinant human IL-2. When cultures were greater
than 80% confluent, cells were passaged 1:2 into addi-
tional wells or into T25 tissue culture flasks. This process
was continued for 14 days to expand T cells. Cultures were
also restimulated at two week intervals with fresh mito-
mycin-C treated autologous splenocytes as above, or 2 ×
106 BM-APC to continue propagation of T cell lines.
Functional assessment of bone marrow-derived APC
BM-APC were examined for functional capacity to process
and present KLH to sensitized autologous deer mouse T
cells expanded in culture. For these experiments, mitomy-
cin-C treated BM-APC (104) or splenocytes (2 × 105) were
used to stimulate 105 T cells in the presence of KLH in 96-
Table 1: Primers used in this work1
Gene Forward Reverse Size (bp)
I-Eβ GTC ATT TCT ACA ACG GGA CG TCT CCG CTG CAC AAT GAA GC 242
TCRβC AGG ACC TGA GCA AGG TGA GC GCA CAG CAT ACA GGG TGG CC 474
β-Actin ATG TAC GTA GCC ATC CAG GC TCT TGC TCG AAG TCT AGG GC 283
GM-CSF 5' RACE N/A GTT GCC CCG TAG GCC CTT CTC ATA TAA CT 273
1All sequences are listed 5' to 3'.BMC Immunology 2004, 5:23 http://www.biomedcentral.com/1471-2172/5/23
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well plates. In other experiments, the effects of house
mouse tumor necrosis factor (20 ng/ml) were evaluated
on APC morphology and capacity to stimulate T cell pro-
liferation. Lastly, antisera to KLH were produced in deer
mice and used to assess the capacity of the BM-APC to
capture and process antigen for presentation to T cells. In
these experiments, antiserum or normal deer mouse
serum were diluted to 1:2,000, a saturating dilution in
ELISA as described above, with KLH and incubated for 1
hour at room temperature. BM-APC and T cells were then
added and the cultures incubated for 72 hours prior to
determining proliferative responses by MTS. Means and
standard deviations were calculated from duplicate
samples.
List of abbreviations
HFRS, hemorrhagic fever with renal syndrome; HCPS,
hantavirus cardiopulmonary syndrome; APC, antigen pre-
senting cell; SNV, Sin Nombre virus; GM-CSF, house
mouse GM-CSF; DC, dendritic cell; CFA, complete Fre-
und's adjuvant; RT-PCR, reverse transcription polymerase
chain reaction; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium
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